Skip to content

TAURIGA SCIENCES, INC.: 10-Q filed 2012-02-21

What TAURIGA SCIENCES, INC. reported in its quarterly report filed 2012-02-21 (fiscal Q3 2011): 23 published measures, 77 facts as tagged in accession 0001424884-12-000013.

This filing

Form
10-Q (quarterly report)
Filed
2012-02-21
Fiscal period
fiscal Q3 2011
Accession
0001424884-12-000013 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TAURIGA SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-31654,557USD
At 2011-03-3117,083USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31-841,110USD
At 2011-03-31-1,647,965USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-325,080USD92
2011-04-01 to 2011-12-31-1,650,711USD275
2008-10-07 to 2011-12-31-7,722,333USD1181
2010-10-01 to 2010-12-31-889,126USD92
2010-04-01 to 2010-12-31-2,225,975USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-04-01 to 2011-12-31-723,753USD275
2008-10-07 to 2011-12-31-2,176,597USD1181
2010-04-01 to 2010-12-31-399,673USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-04-01 to 2011-12-31894,515USD275
2008-10-07 to 2011-12-312,400,677USD1181
2010-04-01 to 2010-12-31348,825USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-04-01 to 2011-12-31-12,700USD275
2008-10-07 to 2011-12-31-26,131USD1181
2010-04-01 to 2010-12-31-2,445USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-3118,256USD
At 2011-03-318,353USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-04-01 to 2011-12-31439,750USD275
2008-10-07 to 2011-12-313,287,845USD1181
2010-04-01 to 2010-12-31795,293USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-31186,301USD
At 2011-03-318,730USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-10-01 to 2011-12-3116,805USD92
2011-04-01 to 2011-12-3160,889USD275
2008-10-07 to 2011-12-31707,072USD1181
2010-10-01 to 2010-12-31206,751USD92
2010-04-01 to 2010-12-31498,873USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-311,495,667USD
At 2011-03-311,665,048USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-31225,086USD
At 2011-03-31222,792USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-10-01 to 2011-12-31308,275USD92
2011-04-01 to 2011-12-311,252,987USD275
2008-10-07 to 2011-12-316,678,426USD1181
2010-10-01 to 2010-12-31682,375USD92
2010-04-01 to 2010-12-311,727,102USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-10-01 to 2011-12-310USD92
2011-04-01 to 2011-12-311,000USD275
2008-10-07 to 2011-12-31987,352USD1181
2010-10-01 to 2010-12-31206,039USD92
2010-04-01 to 2010-12-31544,658USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3182,924,466shares
At 2011-03-3153,245,328shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-12-31-28,406USD
At 2011-03-31-31,157USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2011-10-01 to 2011-12-31329,155USD92
2011-04-01 to 2011-12-311,647,960USD275
2008-10-07 to 2011-12-317,750,739USD1181
2010-10-01 to 2010-12-31889,002USD92
2010-04-01 to 2010-12-312,227,475USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-10-01 to 2011-12-31307,208USD92
2011-04-01 to 2011-12-311,249,190USD275
2008-10-07 to 2011-12-315,683,199USD1181
2010-10-01 to 2010-12-31481,705USD92
2010-04-01 to 2010-12-311,180,346USD275

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-10-01 to 2011-12-311,067USD92
2011-04-01 to 2011-12-312,797USD275
2008-10-07 to 2011-12-317,875USD1181
2010-10-01 to 2010-12-31-5,369USD92
2010-04-01 to 2010-12-312,098USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-04-01 to 2011-12-312,797USD275
2008-10-07 to 2011-12-318,875USD1181
2010-04-01 to 2010-12-312,098USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-16,805USD92
2011-04-01 to 2011-12-31-397,724USD275
2008-10-07 to 2011-12-31-1,043,907USD1181
2010-10-01 to 2010-12-31-206,751USD92
2010-04-01 to 2010-12-31-498,873USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-04-01 to 2011-12-31923,015USD275
2008-10-07 to 2011-12-311,757,938USD1181
2010-04-01 to 2010-12-31348,825USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-12-3112,874USD275
2008-10-07 to 2011-12-31689,362USD1181
2010-04-01 to 2010-12-31109,006USD275

Inspect the source

Entity
TAURIGA SCIENCES, INC. / CIK 0001142790
Captured
SEC response SHA-256
b12e36c5e797d17be657f1f983e9b92007b3470a572d4b591dd9675fa2709825

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001142790.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))